PULMONARY HYPERTENSION, INTERSTITIAL LUNG DISEASE
Clinical trials for PULMONARY HYPERTENSION, INTERSTITIAL LUNG DISEASE explained in plain language.
Never miss a new study
Get alerted when new PULMONARY HYPERTENSION, INTERSTITIAL LUNG DISEASE trials appear
Sign up with your email to follow new studies for PULMONARY HYPERTENSION, INTERSTITIAL LUNG DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Lifeline extended for patients in lung disease drug trial
Disease control AVAILABLEThis study provides continued access to an inhaled medication called TPIP for people with serious lung and heart conditions. It is for patients who have already successfully completed earlier long-term studies of this drug. The goal is to allow these patients to keep receiving a …
Matched conditions: PULMONARY HYPERTENSION, INTERSTITIAL LUNG DISEASE
Sponsor: Insmed Incorporated • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New pill tested to ease deadly lung pressure
Disease control Recruiting nowThis study is testing if adding a new oral drug called ROC-101 to standard treatment is safe and helpful for adults with serious lung blood vessel diseases. About 40 participants with either Pulmonary Arterial Hypertension or a related condition will take the drug daily for 24 we…
Matched conditions: PULMONARY HYPERTENSION, INTERSTITIAL LUNG DISEASE
Phase: PHASE2 • Sponsor: AllRock Bio, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC